Articles about Therapies

‘The Fight Is In Us’ blood plasma campaign deploys Microsoft bot in search of COVID-19 antibodies

A coalition of institutions from life sciences, technology and philanthropy launched a new campaign called “The Fight Is In Us,”… Read More

Adaptive Biotech’s deal with Amgen influenced by belief that COVID-19 may return seasonally, like flu

Despite a potential vaccine, the novel coronavirus could return on a seasonal basis, much like the flu, according to Seattle-based… Read More

Alder BioPharmaceuticals raises $170M in stock offering as FDA reviews its migraine therapy

Alder BioPharmaceuticals has raised $170 million in a stock offering and is ramping up operations after filing an FDA application… Read More

Adaptive Biotechnologies signs blockbuster deal with Genentech for personalized cancer treatments worth up to $2 billion

Adaptive Biotechnologies has signed a $300 million collaborative licensing agreement with Genentech to develop highly personalized cancer therapies. In addition… Read More

PhaseRx liver disease drug receives boost from FDA, stock soars

Seattle-based biotech company PhaseRx develops drug candidates to treat rare, often life-threatening liver diseases, and one of their candidates just got… Read More